131 related articles for article (PubMed ID: 8886511)
1. Markers for cardiovascular and renal morbidity: expectations for an intervention programme in an Australian aboriginal community.
Hoy WE; McFarlane R; Pugsley DJ; Norman R; Mathews JD
Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S33-7. PubMed ID: 8886511
[TBL] [Abstract][Full Text] [Related]
2. Stemming the tide: reducing cardiovascular disease and renal failure in Australian Aborigines.
Hoy W; Kelly A; Jacups S; McKendry K; Baker P; MacDonald S; Wang Z; Punguatji N; Kerinauia J; Tipiloura E; Tipiloura E; Harrison C
Aust N Z J Med; 1999 Jun; 29(3):480-3. PubMed ID: 10868523
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of renal and cardiovascular disease: results of a renal and cardiovascular treatment program in an Australian aboriginal community.
Hoy WE; Wang Z; Baker PR; Kelly AM
J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S178-85. PubMed ID: 12819325
[TBL] [Abstract][Full Text] [Related]
4. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community.
Hoy WE; Wang Z; Baker PR; Kelly AM
Kidney Int Suppl; 2003 Feb; (83):S66-73. PubMed ID: 12864878
[TBL] [Abstract][Full Text] [Related]
5. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community.
Hoy WE; Mathews JD; McCredie DA; Pugsley DJ; Hayhurst BG; Rees M; Kile E; Walker KA; Wang Z
Kidney Int; 1998 Oct; 54(4):1296-304. PubMed ID: 9767547
[TBL] [Abstract][Full Text] [Related]
6. Renal function and cardiovascular risk markers in a remote Australian Aboriginal community.
McDonald SP; Maguire GP; Hoy WE
Nephrol Dial Transplant; 2003 Aug; 18(8):1555-61. PubMed ID: 12897094
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community.
McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
Intern Med J; 2005 May; 35(5):289-94. PubMed ID: 15845111
[TBL] [Abstract][Full Text] [Related]
8. Renal disease in Australian Aborigines.
Hoy W
Nephrol Dial Transplant; 2000 Sep; 15(9):1293-7. PubMed ID: 10978381
[No Abstract] [Full Text] [Related]
9. Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program.
Hoy WE; Baker PR; Kelly AM; Wang Z
Med J Aust; 2000 May; 172(10):473-8. PubMed ID: 10901769
[TBL] [Abstract][Full Text] [Related]
10. The influence of birthweight, past poststreptococcal glomerulonephritis and current body mass index on levels of albuminuria in young adults: the multideterminant model of renal disease in a remote Australian Aboriginal population with high rates of renal disease and renal failure.
Hoy WE; White AV; Tipiloura B; Singh GR; Sharma S; Bloomfield H; Swanson CE; Dowling A; McCredie DA
Nephrol Dial Transplant; 2016 Jun; 31(6):971-7. PubMed ID: 25061125
[TBL] [Abstract][Full Text] [Related]
11. Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort.
Luke JN; Brown AD; Brazionis L; O'Dea K; Best JD; McDermott RA; Wang Z; Wang Z; Rowley KG
Eur J Prev Cardiol; 2013 Apr; 20(2):246-53. PubMed ID: 22345691
[TBL] [Abstract][Full Text] [Related]
12. Risk of CKD in Australian indigenous and nonindigenous children: a population-based cohort study.
Haysom L; Williams R; Hodson E; Lopez-Vargas P; Roy LP; Lyle D; Craig JC
Am J Kidney Dis; 2009 Feb; 53(2):229-37. PubMed ID: 18930569
[TBL] [Abstract][Full Text] [Related]
13. The Austin Doyle Lecture, High Blood Pressure Research Council of Australia. Renal disease as a metaphor: towards a more integrated view of aboriginal health.
Hoy WE
Clin Exp Pharmacol Physiol; 1998 Dec; 25(12):1038-42. PubMed ID: 9888003
[TBL] [Abstract][Full Text] [Related]
14. Albuminuria: marker or target in indigenous populations.
Hoy W; McDonald SP
Kidney Int Suppl; 2004 Nov; (92):S25-31. PubMed ID: 15485412
[TBL] [Abstract][Full Text] [Related]
15. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure.
Hoy WE; Wang Z; VanBuynder P; Baker PR; McDonald SM; Mathews JD
Kidney Int; 2001 Jul; 60(1):249-56. PubMed ID: 11422758
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621
[TBL] [Abstract][Full Text] [Related]
17. The multideterminant model of renal disease in a remote Australian Aboriginal population in the context of early life risk factors: lower birth weight, childhood post-streptococcal glomerulonephritis, and current body mass index influence levels of albuminuria in young Aboriginal adults.
Hoy WE; White AV; Tipiloura B; Singh G; Sharma SK; Bloomfield H; Swanson CE; Dowling A; McCredie DA
Clin Nephrol; 2015; 83(7 Suppl 1):75-81. PubMed ID: 25725247
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population.
Baker PR; Hoy WE; Thomas RE
Adv Chronic Kidney Dis; 2005 Jan; 12(1):22-31. PubMed ID: 15719330
[TBL] [Abstract][Full Text] [Related]
19. CKD in Aboriginal Australians.
Hoy WE; Kincaid-Smith P; Hughson MD; Fogo AB; Sinniah R; Dowling J; Samuel T; Mott SA; Douglas-Denton RN; Bertram JF
Am J Kidney Dis; 2010 Nov; 56(5):983-93. PubMed ID: 20728257
[TBL] [Abstract][Full Text] [Related]
20. Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents.
Kim S; Macaskill P; Hodson EM; Daylight J; Williams R; Kearns R; Vukasin N; Lyle DM; Craig JC
Pediatr Nephrol; 2017 Jan; 32(1):119-129. PubMed ID: 27338727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
